not a primary or secondary outcome of the study and may not have been systematically collected or reported, raising issues of ascertainment bias. This issue is even more challenging because all patients had cognitive impairment. Second, study discontinuation rates were high and there was not a planned, rigorously conducted period of off-drug follow-up. In addition, our analysis updates the published findings from study 078, since a subsequent investigation suggested that these were incomplete.
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C
ognitive decline is a major public health care issue, and a well-recognized clinical manifestation of cognitive decline is falls. Seniors with cognitive impairment fall at twice the rate of peers without cognitive impairment. 1, 2 Exercise training may be an effective strategy against cognitive decline, 3-6 and it is recommended for prevention of falls. We recently reported that 12 months of onceweekly (1ϫRT) or twice-weekly (2ϫRT) resistance training improved selective attention and conflict resolution compared with a balance and tone program (BAT; control) among 155 community-dwelling senior women (ie, Brain Power resistance training study). 4 We also found that both resistance training programs provided better Joseph S. Ross value for falls prevented compared with the BAT program. 7 To our knowledge, no study has examined whether both cognitive and economic benefits of exercise persist after formal cessation. Hence, we examined whether improved selective attention and conflict resolution as well as economic benefits were sustained 12 months after formal cessation of the Brain Power resistance training study. Our primary outcome measure was the specific executive cognitive function of selective attention and conflict resolution, as measured by the Stroop Test. 8 Secondary measures included set shifting, working memory, and current physical activity level.
Methods
Between-group differences in executive cognitive functions were compared by multiple linear regression analyses as in our original trial. 4 For current physical activity level, baseline score and experimental group were used as covariates. Two planned simple contrasts were performed to assess differences between (1) the 1ϫRT group and the BAT group and (2) the 2ϫRT group and the BAT group. The overall ␣ level was set at P Ͻ.05.
For the economic evaluation, we calculated the incremental cost per fall prevented for both 1ϫRT and 2ϫRT groups compared with the BAT group from a Canadian Health Care System perspective using a 21-month time horizon (2009 prices). All hospital admission-related costs were based on a fully allocated cost model of a tertiary care hospital or the British Columbia Medical Services Plan 2009 price list.
Results. Of the 123 who consented, 109 completed the assessment at the end of the 12-month follow-up (37 from the 1ϫRT group, 41 from the 2ϫRT group, and 31 from the BAT group). The mean (SD) age of the cohort was 71.6 (3.0) years.
There was a significant between-group difference in selective attention and conflict resolution at the end of the 12-month follow-up study (P = .04). Specifically, the 1 ϫ RT group sustained improved Stroop test performance compared with the BAT group (P = .04) (Table) . There were no significant between-group differences in set shifting, working memory, and current physical activity level.
The unadjusted incidence rate ratio over the 2-year period for the 1ϫRT group indicated a 30% (incidence rate ratio, 0.70; 95% confidence interval, 0.37-1.33) nonsignificant reduction in falls and an 8% (incidence rate ratio, 1.08; 95% confidence interval, 0.79-1.47) nonsignificant increase in the 2ϫRT group.
On the basis of the point estimates from our base case analysis, we found that the 1ϫRT group incurred fewer health care resource utilization costs and had fewer falls than the BAT group; thus, 1ϫRT was less costly and more effective than BAT. Although the 2ϫRT group also incurred fewer care utilization costs than BAT, the 2ϫRT group sustained more falls. Thus, 2ϫRT was less effective than BAT.
Comment. We provide novel data suggesting that both the cognitive and economic benefits of once-weekly resistance training can be sustained 12 months after its formal cessation. Specifically, 12 months after trial completion, former participants of the 1ϫRT group demonstrated a 15% improvement in their performance on the Stroop test compared with those in the BAT group. This novel finding strengthens the emerging belief that targeted exercise training may combat age-related decreases in cognitive function. Furthermore, there was a significant reduction in health care resource utilization costs of falls 12 months after trial completion for the 1ϫRT and 2ϫRT groups compared with the BAT (control) group. Thus, both cognitive and economic benefits of participating in a 12-month resistance training intervention were sustained for the 1ϫRT group, whereas these benefits were not sustained for the 2 ϫ RT group. The 1 ϫ RT group demonstrated a 5% increase (PϾ .05) in current physical activity level from baseline compared with a 6.6% reduction (PϾ .05) in the 2ϫ RT group. Hence, maintaining physical activity level may be essential in sustaining the benefits of resistance training. Such findings should remain guarded as future studies investigate factors that : We thank the Vancouver South Slope YMCA management and members who enthusiastically supported the study by allowing access to participants for the training intervention and the instructors for their commitment to the participants' health and safety.
